Adult growth hormone deficiency: Optimizing transition of care from pediatric to adult services.


Journal

Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society
ISSN: 1532-2238
Titre abrégé: Growth Horm IGF Res
Pays: Scotland
ID NLM: 9814320

Informations de publication

Date de publication:
02 2021
Historique:
received: 29 07 2020
revised: 23 11 2020
accepted: 06 12 2020
pubmed: 21 12 2020
medline: 15 2 2022
entrez: 20 12 2020
Statut: ppublish

Résumé

Most patients with childhood-onset growth hormone deficiency (CO-GHD) receive treatment with exogenous growth hormone (GH) to facilitate the attainment of their full potential adult height. Recent evidence suggests that continuing GH administration during the transition period between the end of linear growth and full adult maturity is necessary for proper body composition and bone and muscle health, and may also have beneficial effects on metabolic parameters, bone mineral density, and quality of life. The timing of this transition period coincides with the transfer of care from a pediatric to an adult endocrinologist, creating the potential for a care gap as a consequence of losing the patient to follow-up. An advisory board comprising both pediatric and adult endocrinologists was assembled to address current clinical unmet needs and to collaborate on a structured transitional plan for optimal management of patients with CO-GHD. The advisors suggest collaborative, multidisciplinary approaches to ensure continuity of care; ongoing testing and monitoring of GHD status into adulthood; and a clearly structured protocol that includes practical guidance for clinicians to establish best practices for transitioning older adolescents with persistent CO-GHD to adult care.

Identifiants

pubmed: 33341524
pii: S1096-6374(20)30084-8
doi: 10.1016/j.ghir.2020.101375
pii:
doi:

Substances chimiques

Human Growth Hormone 12629-01-5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

101375

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Kevin C J Yuen (KCJ)

Barrow Pituitary Center, Barrow Neurological Institute, University of Arizona College of Medicine, Creighton School of Medicine, Phoenix, AZ, United States of America.

Craig A Alter (CA)

Perelman School of Medicine, University of Pennsylvania, Children's Hospital of Philadelphia, Philadelphia, PA, United States of America.

Bradley S Miller (BS)

Pediatric Endocrinology, University of Minnesota Masonic Children's Hospital, Minneapolis, MN, United States of America.

Anthony W Gannon (AW)

Nemours/Alfred I. DuPont Hospital for Children, Wilmington, DE, United States of America.

Nicholas A Tritos (NA)

Massachusetts General Hospital, Neuroendocrine Unit, Harvard Medical School, Boston, MA, United States of America.

Susan L Samson (SL)

Pituitary Center, Baylor St. Luke's Medical Center, Baylor College of Medicine, Houston, TX, United States of America.

Georgiana Dobri (G)

Neurological Surgery and Endocrinology Departments, Weill Cornell Medicine, New York, NY, United States of America.

Kristine Kurtz (K)

Novo Nordisk Inc., Plainsboro, NJ, United States of America.

Frank Strobl (F)

Novo Nordisk Inc., Plainsboro, NJ, United States of America.

Nicky Kelepouris (N)

Novo Nordisk Inc., Plainsboro, NJ, United States of America. Electronic address: nlkp@novonordisk.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH